BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 14534046)

  • 1. An assessment of the impact of thimerosal on childhood neurodevelopmental disorders.
    Geier DA; Geier MR
    Pediatr Rehabil; 2003; 6(2):97-102. PubMed ID: 14534046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurodevelopmental disorders following thimerosal-containing childhood immunizations: a follow-up analysis.
    Geier D; Geier MR
    Int J Toxicol; 2004; 23(6):369-76. PubMed ID: 15764492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thimerosal exposure in infants and developmental disorders: a retrospective cohort study in the United kingdom does not support a causal association.
    Andrews N; Miller E; Grant A; Stowe J; Osborne V; Taylor B
    Pediatrics; 2004 Sep; 114(3):584-91. PubMed ID: 15342825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative evaluation of the effects of MMR immunization and mercury doses from thimerosal-containing childhood vaccines on the population prevalence of autism.
    Geier DA; Geier MR
    Med Sci Monit; 2004 Mar; 10(3):PI33-9. PubMed ID: 14976450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An evaluation of the effects of thimerosal on neurodevelopmental disorders reported following DTP and Hib vaccines in comparison to DTPH vaccine in the United States.
    Geier DA; Geier MR
    J Toxicol Environ Health A; 2006 Aug; 69(15):1481-95. PubMed ID: 16766480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A meta-analysis epidemiological assessment of neurodevelopmental disorders following vaccines administered from 1994 through 2000 in the United States.
    Geier DA; Geier MR
    Neuro Endocrinol Lett; 2006 Aug; 27(4):401-13. PubMed ID: 16807526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurodevelopmental disorders after thimerosal-containing vaccines: a brief communication.
    Geier MR; Geier DA
    Exp Biol Med (Maywood); 2003 Jun; 228(6):660-4. PubMed ID: 12773696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thimerosal-containing vaccines and autistic spectrum disorder: a critical review of published original data.
    Parker SK; Schwartz B; Todd J; Pickering LK
    Pediatrics; 2004 Sep; 114(3):793-804. PubMed ID: 15342856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An assessment of downward trends in neurodevelopmental disorders in the United States following removal of Thimerosal from childhood vaccines.
    Geier DA; Geier MR
    Med Sci Monit; 2006 Jun; 12(6):CR231-9. PubMed ID: 16733480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thimerosal exposure in infants and developmental disorders: a prospective cohort study in the United kingdom does not support a causal association.
    Heron J; Golding J;
    Pediatrics; 2004 Sep; 114(3):577-83. PubMed ID: 15342824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A two-phased population epidemiological study of the safety of thimerosal-containing vaccines: a follow-up analysis.
    Geier DA; Geier MR
    Med Sci Monit; 2005 Apr; 11(4):CR160-70. PubMed ID: 15795695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thimerosal exposure in infants and neurodevelopmental disorders: an assessment of computerized medical records in the Vaccine Safety Datalink.
    Young HA; Geier DA; Geier MR
    J Neurol Sci; 2008 Aug; 271(1-2):110-8. PubMed ID: 18482737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mercury in vaccines].
    Hessel L
    Bull Acad Natl Med; 2003; 187(8):1501-10. PubMed ID: 15146581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exposure to thimerosal in vaccines used in Canadian infant immunization programs, with respect to risk of neurodevelopmental disorders.
    Bigham M; Copes R; Srour L
    Can Commun Dis Rep; 2002 May; 28(9):69-80. PubMed ID: 12012653
    [No Abstract]   [Full Text] [Related]  

  • 15. Continuing increases in autism reported to California's developmental services system: mercury in retrograde.
    Schechter R; Grether JK
    Arch Gen Psychiatry; 2008 Jan; 65(1):19-24. PubMed ID: 18180424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evaluation of serious neurological disorders following immunization: a comparison of whole-cell pertussis and acellular pertussis vaccines.
    Geier DA; Geier MR
    Brain Dev; 2004 Aug; 26(5):296-300. PubMed ID: 15165669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lack of association between thimerosal-containing vaccines and autism].
    Mrozek-Budzyn D; Majewska R; Kiełtyka A; Augustyniak M
    Przegl Epidemiol; 2011; 65(3):491-5. PubMed ID: 22184954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccines and autism: evidence does not support a causal association.
    DeStefano F
    Clin Pharmacol Ther; 2007 Dec; 82(6):756-9. PubMed ID: 17928818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Addressing the controversy regarding the association between thimerosal-containing vaccines and autism].
    García-Fernández L; Hernández AV; Suárez Moreno V; Fiestas F
    Rev Peru Med Exp Salud Publica; 2013 Apr; 30(2):268-74. PubMed ID: 23949514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between thimerosal-containing vaccine and autism.
    Hviid A; Stellfeld M; Wohlfahrt J; Melbye M
    JAMA; 2003 Oct; 290(13):1763-6. PubMed ID: 14519711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.